Baclofen treatment for chronic posttraumatic stress disorder

Annals of Pharmacotherapy

Volumn 37, Issue 9, 2003, Pages 1177-1181

  Drake, Roger G ^a   Davis, Lori L ^b,c   Cates, Marshall E ^c,d   Jewell, Michele E ^c   Ambrose, Sandra M ^c   Lowe, Joette S ^c  

^a Department of Clinical Pharmacy   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d SAMFORD UNIVERSITY   (United States)

Author keywords

aminobutyric acid; Anxiety disorders; Baclofen; Posttraumatic stress disorder

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; BACLOFEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; CONSTIPATION; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FOLLOW UP; HEADACHE; HUMAN; LIBIDO; MALE; MONOTHERAPY; MUSCLE WEAKNESS; NAUSEA; OPEN STUDY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SEXUAL DYSFUNCTION; SIDE EFFECT; TIME SERIES ANALYSIS; TREATMENT OUTCOME; VERTIGO; XEROSTOMIA;

ADULT; AGED; BACLOFEN; CHRONIC DISEASE; COMBAT DISORDERS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, GABA-B; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; VETERANS; WAR;

EID: 0041923830     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C465     Document Type: Article

References (19)

1. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
2. Davis LL, Suris A, Lambert MT, Heimberg C, Petty F. Post-traumatic stress disorder and serotonin: new directions for research and treatment. J Psychiatry Neurosci 1997;22:318-26.
3. Lambert MT, Hendrickse W, Andrews R, Zelanko J, Fowler DR. Malignant post-Vietnam stress syndrome revisited. J Nerv Ment Dis 1996; 184:354-7.
4. Davis LL, English BA, Ambrose SM, Petty F. Pharmacotherapy for post-traumatic stress disorder: a comprehensive review. Expert Opin Pharmacother 2001;2:1583-95.
5. Breslow MF, Fankhauser MP, Potter RL, Meredith KE, Misiaszek J, Hope DG Jr. Role of γ-aminobutyric acid in antipanic drug efficacy. Am J Psychiatry 1989;146:353-6.
6. Davis LL, Kabel D, Patel D, Choate AD, Foslien-Nash C, Gurguis GNM, et al. Valproate as an antidepressant in major depressive disorder. Psychopharmacol Bull 1996;32:647-52.
7. B agonist baclofen in major depressive disorder. Psychoneuroendocrinology 1997;22:129-40.
8. Krupitsky EM, Burakov AM, Ivanov GF, Krandashova GF, Lapin IP, Grinenko AJ, et al. Baclofen administration for the treatment of affective disorders in alcoholic patients. Drug Alcohol Depend 1993;33:157-63.
9. B receptor systems in action of antidepressants II: baclofen attenuates the effect of desipramine whereas muscimol has no effect in learned helplessness paradigm in rats. Brain Res 1996;728:225-30.
10. Petty F. GABA and mood disorders: a brief review and hypothesis. J Affect Disord 1995;34:275-81.
11. Petty F, Kramer GL, Hendrickse W. GABA and depression. In: Mann JJ, Kupfer DJ, eds. Biology of depressive disorders, part A: a systems perspective. New York: Plenum Press, 1993:79-108.
12. Vaiva G, Boss V, Addesa G, Cottencin O, Fontaine M, Fontaine C, et al. Low GABA levels and posttraumatic stress disorder (abstract). International Society of Traumatic Stress Studies, San Antonio, TX, November 17, 2000.
13. Paul SM. GABA and glycine. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995:87-94.
14. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. The development of a clinician-administered PTSD scale. J Trauma Stress 1995;8:75-90.
15. Martenyi F, Brown EB, Zhang H, Prakash A, Koke SC. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry 2002;63: 199-206.
16. Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 2001; 58:485-92.
17. Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 2001;62:860-8.
18. Hidalgo R, Hertzberg MA, Mellman T, Petty F, Tucker P, Weisler R, et al. Nefazodone in post-traumatic stress disorder: results from six openlabel trials. Int Clin Psychopharmacol 1999;14:61-8.
19. Davidson JR. Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome. J Clin Psychiatry 2000;61(suppl 5):52-9.